Susan Hasty, Publisher
Table of Contents . . . July 5th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Adverse Drug Effects - Severe infections plague acute alcoholic hepatitis patients given infliximab
Chronic Liver Disease - Steatosis exacerbates liver injury in patients with chronic hepatitis C
Hepatology - Insulin resistance helps predict chronic hepatitis C-related liver fibrosis
Immunology - CD8+ T-cell expansion impedes interferon's efforts against hepatitis C virus
Liver Transplantation - Intramuscular hepatitis B immunoglobulin offers advantages to liver recipients
Addiction Medicine - Zinc controls nuclear factor-kappa B activation to protect against liver injury
Angiology - Interventional radiology manages vascular complications after liver transplants
Awards - Warren Alpert Foundation Prize awarded to interferon therapy researchers
Business Update - Isis gains full ownership of Orasense and HepaSense subsidiaries
Cancer Therapy - Trial results reported in HGS-ETR1 in patients with advanced cancers
Cirrhosis - LPS-binding protein predicts infection in cirrhotic patients
Diabetes Risk Factor - Diabetes associated with lichen planus cases in Turkey
Diagnostics - Megamitochondrial artifacts randomize in nonalcoholic steatohepatitis livers
Fatty Liver Disease - Wy-14,643 reverses nutritional fibrosis and steatohepatitis in animal models
HIV/AIDS Anemia - Management strategy for anemia in HIV infection elucidated
Hepatitis - Hepatitis E virus in human feces detected and quantitated by real-time PCR
Hepatitis C Virus Epidemiology - Hepatitis C reigns among mental health patients and substance abusers in Japan
Hepatitis Coinfection - HBV/HIV coinfected patients increased risk for virologic failure after HAART
Hepatitis D Virus - Hepatitis delta virus ribozymes are controlled by a conformational switch
Hepatitis Screening - VA to host free hepatitis C screening for veterans
Legal Issues - Ribavirin patent infringement case dismissed
Liver Disease - Interleukin 22 is a liver cell survival factor in murine liver injury models
Liver Injury - The CXCR3 ligand I-TAC correlates with chronic hepatitis C-related inflammation
Personnel - Research and development company adds new member to scientific advisory board
Quality Assurance - Hospital says flawed cleaning procedure may have exposed patients to viruses
Renal Transplantation - Interferon blocks HCV-induced renal injury after transplantation
Substance Abuse - Scottish study of deaths in drug injectors shows early help is critical
Therapeutics - Systemic efficacy of siRNAs demonstrated in multiple animal models
Viral Genomics and Gentics - Hepatitis C virus genotype 1a responds to a host of immunodominant epitopes
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.